Company Filing History:
Years Active: 2022
Title: The Innovations of Marc Pentopoulos
Introduction
Marc Pentopoulos is an accomplished inventor based in Palo Alto, California. He has made significant contributions to the field of medicine, particularly in the treatment of neonatal abstinence syndrome (NAS). His innovative work has the potential to improve the lives of many newborns affected by this condition.
Latest Patents
Marc Pentopoulos holds a patent for "Oxytocin compositions and methods of use." This patent discloses oxytocin compositions that contain a therapeutically effective amount of oxytocin, an analog or derivative of oxytocin, or an oxytocin receptor agonist for the treatment of NAS in a subject. The patent also outlines methods for administering these compositions to effectively treat NAS.
Career Highlights
Throughout his career, Marc has demonstrated a commitment to advancing medical science. His work at Elgan Pharma Ltd. showcases his dedication to developing innovative solutions for pressing health issues. With a focus on neonatal care, he aims to make a lasting impact in the medical community.
Collaborations
Marc has collaborated with notable professionals in his field, including Dean Carson and Dean S Carson. These partnerships have allowed him to enhance his research and contribute to the development of effective treatments.
Conclusion
Marc Pentopoulos is a pioneering inventor whose work in oxytocin compositions holds promise for treating neonatal abstinence syndrome. His contributions to medicine reflect his dedication to improving health outcomes for vulnerable populations.